Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Takeda to sell OTC and non-core assets to Orifarm for $670m

pharmaceutical-technologyApril 26, 2020

Tag: Takeda , Orifarm , OTC

PharmaSources Customer Service